Article
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
Human molecular genetics - 1 Oct 2015
Oppici Elisa, Fargue Sonia, Reid Emma S, Mills Philippa B, Clayton Peter T, Danpure Christopher J, Cellini Barbara
Abstract excerpt
Vitamin B6 in the form of pyridoxine (PN) is one of the most widespread pharmacological therapies for inherited diseases involving pyridoxal phosphate (PLP)-dependent enzymes, including primary hyperoxaluria type I (PH1). PH1 is caused by a deficiency of liver-peroxisomal alanine: glyoxylate aminotransferase (AGT), which allows glyoxylate oxidation to oxalate leading to the deposition of insoluble calcium oxalate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.